Pulmonary nodule | Parameter | BV | BF | MTT | PS | PH | PHpm/PHa (100%) | MVD |
---|---|---|---|---|---|---|---|---|
Peripheral lung cancer | VEGF positive expression (n = 29) | 11.457 ± 3.593 | 225.406 ± 83.556 | 7.326 ± 3.807 | 21.638 ± 7.050 | 62.531 ± 8.579 | 21.285 ± 3.238 | 32.495 ± 14.541 |
 | VEGF negative expression (n = 10) | 8.025 ± 2.859 | 146.728 ± 88.744 | 7.896 ± 3.787 | 14.090 ± 6.785 | 55.740 ± 5.132 | 18.657 ± 2.466 | 20.002 ± 9.363 |
 | F | 7.449 | 6.394 | 0.167 | 8.680 | 5.522 | 5.455 | 6.400 |
 | P | 0.010 | 0.016 | 0.685 | 0.006 | 0.024 | 0.025 | 0.016 |
Inflammatory nodule | VEGF positive expression (n = 0) | / | / | / | / | / | / | / |
 | VEGF negative expression (n = 13) | 8.542 ± 2.581 | 160.902 ± 68.412 | 6.397 ± 3.292 | 4.019 ± 1.730 | 65.700 ± 5.948 | 22.163 ± 2.240 | 33.966 ± 15.548 |
Benign nodule | VEGF positive expression (n = 3) | 6.620 ± 2.231 | 83.070 ± 25.153 | 6.320 ± 1.890 | 5.047 ± 2.945 | 30.733 ± 14.199 | 9.793 ± 4.177 | 8.877 ± 3.285 |
 | VEGF negative expression (n = 9) | 5.534 ± 1.439 | 79.954 ± 13.919 | 5.573 ± 3.222 | 3.380 ± 1.903 | 26.867 ± 7.652 | 8.592 ± 2.168 | 7.653 ± 2.081 |
 | F | 1.000 | 0.078 | 0.139 | 1.350 | 0.386 | 0.448 | 0.599 |
 | P | 0.341 | 0.786 | 0.717 | 0.272 | 0.548 | 0.519 | 0.457 |